(ORLY) O’Reilly Automotive - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US67103H1077
Stock: Auto Parts, Tools, Accessories, Supplies
Total Rating 52
Risk 55
Buy Signal -0.60
| Risk 5d forecast | |
|---|---|
| Volatility | 20.8% |
| Relative Tail Risk | 0.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.22 |
| Alpha | -1.56 |
| Character TTM | |
|---|---|
| Beta | 0.269 |
| Beta Downside | 0.402 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.07% |
| CAGR/Max DD | 1.12 |
EPS (Earnings per Share)
Revenue
Description: ORLY O’Reilly Automotive March 04, 2026
OReilly Automotive, Inc. (ORLY) is an automotive aftermarket parts retailer and supplier.
The company sells new and remanufactured automotive hard parts, maintenance items, and accessories. This includes a wide range of products from alternators and batteries to engine parts and fluids. The automotive aftermarket sector is generally resilient, as vehicle maintenance is often a non-discretionary expense.
ORLY also provides various services such as used oil recycling, battery replacement, diagnostic testing, and a loaner tool program. These services cater to both do-it-yourself (DIY) customers and professional service providers, a common dual-market strategy in this industry.
The company operates in the United States, Puerto Rico, Mexico, and Canada, offering products under multiple proprietary brands. To gain more insights into their market position, consider exploring their competitive landscape on ValueRay.
Founded in 1957, OReilly Automotive is headquartered in Springfield, Missouri.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 2.54b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -3.97 > 1.0 |
| NWC/Revenue: -11.42% < 20% (prev -14.62%; Δ 3.20% < -1%) |
| CFO/TA 0.17 > 3% & CFO 2.76b > Net Income 2.54b |
| Net Debt (10.33b) to EBITDA (3.99b): 2.59 < 3 |
| Current Ratio: 0.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (848.4m) vs 12m ago 1.17% < -2% |
| Gross Margin: 51.59% > 18% (prev 0.51%; Δ 5108 % > 0.5%) |
| Asset Turnover: 113.1% > 50% (prev 112.2%; Δ 0.96% > 0%) |
| Interest Coverage Ratio: 14.78 > 6 (EBITDA TTM 3.99b / Interest Expense TTM 235.1m) |
Altman Z'' 0.08
| A: -0.12 (Total Current Assets 6.74b - Total Current Liabilities 8.78b) / Total Assets 16.54b |
| B: -0.14 (Retained Earnings -2.33b / Total Assets 16.54b) |
| C: 0.22 (EBIT TTM 3.48b / Avg Total Assets 15.72b) |
| D: -0.13 (Book Value of Equity -2.29b / Total Liabilities 17.30b) |
| Altman-Z'' Score: 0.08 = B |
Beneish M -3.02
| DSRI: 1.04 (Receivables 549.7m/495.9m, Revenue 17.78b/16.71b) |
| GMI: 0.99 (GM 51.59% / 51.20%) |
| AQI: 0.92 (AQ_t 0.07 / AQ_t-1 0.08) |
| SGI: 1.06 (Revenue 17.78b / 16.71b) |
| TATA: -0.01 (NI 2.54b - CFO 2.76b) / TA 16.54b) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
What is the price of ORLY shares?
As of March 08, 2026, the stock is trading at USD 94.60 with a total of 5,912,206 shares traded.
Over the past week, the price has changed by +0.77%, over one month by +0.40%, over three months by -3.58% and over the past year by +6.61%.
Over the past week, the price has changed by +0.77%, over one month by +0.40%, over three months by -3.58% and over the past year by +6.61%.
Is ORLY a buy, sell or hold?
O’Reilly Automotive has received a consensus analysts rating of 4.14.
Therefore, it is recommended to buy ORLY.
- StrongBuy: 14
- Buy: 6
- Hold: 7
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the ORLY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 105.7 | 11.8% |
| Analysts Target Price | 105.7 | 11.8% |
ORLY Fundamental Data Overview March 05, 2026
P/E Trailing = 31.6061
P/E Forward = 29.9401
P/S = 4.456
P/B = 210.1772
P/EG = 2.1923
Revenue TTM = 17.78b USD
EBIT TTM = 3.48b USD
EBITDA TTM = 3.99b USD
Long Term Debt = 5.92b USD (from longTermDebt, two quarters ago)
Short Term Debt = 439.9m USD (from shortTermDebt, last quarter)
Debt = 10.53b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.33b USD (from netDebt column, last quarter)
Enterprise Value = 89.57b USD (79.24b + Debt 10.53b - CCE 193.8m)
Interest Coverage Ratio = 14.78 (Ebit TTM 3.48b / Interest Expense TTM 235.1m)
EV/FCF = 56.22x (Enterprise Value 89.57b / FCF TTM 1.59b)
FCF Yield = 1.78% (FCF TTM 1.59b / Enterprise Value 89.57b)
FCF Margin = 8.96% (FCF TTM 1.59b / Revenue TTM 17.78b)
Net Margin = 14.27% (Net Income TTM 2.54b / Revenue TTM 17.78b)
Gross Margin = 51.59% ((Revenue TTM 17.78b - Cost of Revenue TTM 8.61b) / Revenue TTM)
Gross Margin QoQ = 51.79% (prev 51.85%)
Tobins Q-Ratio = 5.42 (Enterprise Value 89.57b / Total Assets 16.54b)
Interest Expense / Debt = 0.58% (Interest Expense 60.6m / Debt 10.53b)
Taxrate = 21.47% (165.5m / 770.7m)
NOPAT = 2.73b (EBIT 3.48b * (1 - 21.47%))
Current Ratio = 0.77 (Total Current Assets 6.74b / Total Current Liabilities 8.78b)
Debt / Equity = -13.79 (negative equity) (Debt 10.53b / totalStockholderEquity, last quarter -763.4m)
Debt / EBITDA = 2.59 (Net Debt 10.33b / EBITDA 3.99b)
Debt / FCF = 6.49 (Net Debt 10.33b / FCF TTM 1.59b)
Total Stockholder Equity = -1.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.15% (Net Income 2.54b / Total Assets 16.54b)
RoE = -239.0% (negative equity) (Net Income TTM 2.54b / Total Stockholder Equity -1.06b)
RoCE = 71.60% (EBIT 3.48b / Capital Employed (Equity -1.06b + L.T.Debt 5.92b))
RoIC = 58.87% (NOPAT 2.73b / Invested Capital 4.64b)
WACC = 6.15% (E(79.24b)/V(89.76b) * Re(6.91%) + D(10.53b)/V(89.76b) * Rd(0.58%) * (1-Tc(0.21)))
Discount Rate = 6.91% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.24%
[DCF] Terminal Value 83.78% ; FCFF base≈1.77b ; Y1≈1.55b ; Y5≈1.26b
[DCF] Fair Price = 29.75 (EV 35.38b - Net Debt 10.33b = Equity 25.04b / Shares 841.9m; r=6.15% [WACC]; 5y FCF grow -15.03% → 2.90% )
EPS Correlation: 75.50 | EPS CAGR: 11.00% | SUE: -0.60 | # QB: 0
Revenue Correlation: 88.52 | Revenue CAGR: 8.10% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.86 | Chg7d=-0.016 | Chg30d=-0.017 | Revisions Net=-10 | Analysts=19
EPS current Year (2026-12-31): EPS=3.23 | Chg7d=-0.083 | Chg30d=-0.076 | Revisions Net=-14 | Growth EPS=+8.9% | Growth Revenue=+6.5%
EPS next Year (2027-12-31): EPS=3.59 | Chg7d=-0.079 | Chg30d=-0.073 | Revisions Net=-11 | Growth EPS=+11.0% | Growth Revenue=+6.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 10 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.8% (Discount Rate 7.9% - Earnings Yield 3.2%)
[Growth] Growth Spread = +2.3% (Analyst 7.1% - Implied 4.8%)
P/E Forward = 29.9401
P/S = 4.456
P/B = 210.1772
P/EG = 2.1923
Revenue TTM = 17.78b USD
EBIT TTM = 3.48b USD
EBITDA TTM = 3.99b USD
Long Term Debt = 5.92b USD (from longTermDebt, two quarters ago)
Short Term Debt = 439.9m USD (from shortTermDebt, last quarter)
Debt = 10.53b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.33b USD (from netDebt column, last quarter)
Enterprise Value = 89.57b USD (79.24b + Debt 10.53b - CCE 193.8m)
Interest Coverage Ratio = 14.78 (Ebit TTM 3.48b / Interest Expense TTM 235.1m)
EV/FCF = 56.22x (Enterprise Value 89.57b / FCF TTM 1.59b)
FCF Yield = 1.78% (FCF TTM 1.59b / Enterprise Value 89.57b)
FCF Margin = 8.96% (FCF TTM 1.59b / Revenue TTM 17.78b)
Net Margin = 14.27% (Net Income TTM 2.54b / Revenue TTM 17.78b)
Gross Margin = 51.59% ((Revenue TTM 17.78b - Cost of Revenue TTM 8.61b) / Revenue TTM)
Gross Margin QoQ = 51.79% (prev 51.85%)
Tobins Q-Ratio = 5.42 (Enterprise Value 89.57b / Total Assets 16.54b)
Interest Expense / Debt = 0.58% (Interest Expense 60.6m / Debt 10.53b)
Taxrate = 21.47% (165.5m / 770.7m)
NOPAT = 2.73b (EBIT 3.48b * (1 - 21.47%))
Current Ratio = 0.77 (Total Current Assets 6.74b / Total Current Liabilities 8.78b)
Debt / Equity = -13.79 (negative equity) (Debt 10.53b / totalStockholderEquity, last quarter -763.4m)
Debt / EBITDA = 2.59 (Net Debt 10.33b / EBITDA 3.99b)
Debt / FCF = 6.49 (Net Debt 10.33b / FCF TTM 1.59b)
Total Stockholder Equity = -1.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.15% (Net Income 2.54b / Total Assets 16.54b)
RoE = -239.0% (negative equity) (Net Income TTM 2.54b / Total Stockholder Equity -1.06b)
RoCE = 71.60% (EBIT 3.48b / Capital Employed (Equity -1.06b + L.T.Debt 5.92b))
RoIC = 58.87% (NOPAT 2.73b / Invested Capital 4.64b)
WACC = 6.15% (E(79.24b)/V(89.76b) * Re(6.91%) + D(10.53b)/V(89.76b) * Rd(0.58%) * (1-Tc(0.21)))
Discount Rate = 6.91% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.24%
[DCF] Terminal Value 83.78% ; FCFF base≈1.77b ; Y1≈1.55b ; Y5≈1.26b
[DCF] Fair Price = 29.75 (EV 35.38b - Net Debt 10.33b = Equity 25.04b / Shares 841.9m; r=6.15% [WACC]; 5y FCF grow -15.03% → 2.90% )
EPS Correlation: 75.50 | EPS CAGR: 11.00% | SUE: -0.60 | # QB: 0
Revenue Correlation: 88.52 | Revenue CAGR: 8.10% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.86 | Chg7d=-0.016 | Chg30d=-0.017 | Revisions Net=-10 | Analysts=19
EPS current Year (2026-12-31): EPS=3.23 | Chg7d=-0.083 | Chg30d=-0.076 | Revisions Net=-14 | Growth EPS=+8.9% | Growth Revenue=+6.5%
EPS next Year (2027-12-31): EPS=3.59 | Chg7d=-0.079 | Chg30d=-0.073 | Revisions Net=-11 | Growth EPS=+11.0% | Growth Revenue=+6.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 10 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.8% (Discount Rate 7.9% - Earnings Yield 3.2%)
[Growth] Growth Spread = +2.3% (Analyst 7.1% - Implied 4.8%)